1. Home
  2. VERO vs HSCS Comparison

VERO vs HSCS Comparison

Compare VERO & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Venus Concept Inc.

VERO

Venus Concept Inc.

HOLD

Current Price

$1.82

Market Cap

4.0M

Sector

Health Care

ML Signal

HOLD

Logo Heart Test Laboratories Inc.

HSCS

Heart Test Laboratories Inc.

HOLD

Current Price

$2.69

Market Cap

7.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VERO
HSCS
Founded
N/A
2007
Country
Canada
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0M
7.5M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
VERO
HSCS
Price
$1.82
$2.69
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$10.50
AVG Volume (30 Days)
35.0K
36.4K
Earning Date
11-13-2025
12-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$58,876,000.00
$6,250.00
Revenue This Year
N/A
N/A
Revenue Next Year
$10.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.65
$2.01
52 Week High
$14.50
$6.47

Technical Indicators

Market Signals
Indicator
VERO
HSCS
Relative Strength Index (RSI) 46.16 42.26
Support Level $1.84 $2.55
Resistance Level $1.99 $3.00
Average True Range (ATR) 0.12 0.23
MACD 0.01 0.02
Stochastic Oscillator 44.78 29.69

Price Performance

Historical Comparison
VERO
HSCS

About VERO Venus Concept Inc.

Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.

About HSCS Heart Test Laboratories Inc.

HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.

Share on Social Networks: